Cost differential of immuno-oncology therapy delivered at community versus hospital clinics.

CONCLUSIONS: Treatment with I-O therapies in community practice is associated with a lower total cost of care compared with that in hospital-based outpatient practices. With the expanding indications of these agents, future research is needed.
PMID: 30875173 [PubMed - in process]

Source: The American Journal of Managed Care - February 28, 2019 Category: Health Management Authors: Gordan L, Blazer M, Saundankar V, Kazzaz D, Weidner S, Eaddy M Tags: Am J Manag Care Source Type: research